360 related articles for article (PubMed ID: 24815737)
1. De novo oligoclonal expansions of circulating plasmablasts in active and relapsing IgG4-related disease.
Mattoo H; Mahajan VS; Della-Torre E; Sekigami Y; Carruthers M; Wallace ZS; Deshpande V; Stone JH; Pillai S
J Allergy Clin Immunol; 2014 Sep; 134(3):679-87. PubMed ID: 24815737
[TBL] [Abstract][Full Text] [Related]
2. Circulating plasmablasts/plasma cells: a potential biomarker for IgG4-related disease.
Lin W; Zhang P; Chen H; Chen Y; Yang H; Zheng W; Zhang X; Zhang F; Zhang W; Lipsky PE
Arthritis Res Ther; 2017 Feb; 19(1):25. PubMed ID: 28183334
[TBL] [Abstract][Full Text] [Related]
3. Clonal expansion of CD4(+) cytotoxic T lymphocytes in patients with IgG4-related disease.
Mattoo H; Mahajan VS; Maehara T; Deshpande V; Della-Torre E; Wallace ZS; Kulikova M; Drijvers JM; Daccache J; Carruthers MN; Castelino FV; Stone JR; Stone JH; Pillai S
J Allergy Clin Immunol; 2016 Sep; 138(3):825-838. PubMed ID: 26971690
[TBL] [Abstract][Full Text] [Related]
4. Enhanced IgG4 production by follicular helper 2 T cells and the involvement of follicular helper 1 T cells in the pathogenesis of IgG4-related disease.
Akiyama M; Yasuoka H; Yamaoka K; Suzuki K; Kaneko Y; Kondo H; Kassai Y; Koga K; Miyazaki T; Morita R; Yoshimura A; Takeuchi T
Arthritis Res Ther; 2016 Jul; 18():167. PubMed ID: 27411315
[TBL] [Abstract][Full Text] [Related]
5. Effects of glucocorticoids on B-cell subpopulations in patients with IgG4-related disease.
Lanzillotta M; Della-Torre E; Milani R; Bozzolo E; Bozzalla-Cassione E; Rovati L; Arcidiacono PG; Partelli S; Falconi M; Ciceri F; Dagna L
Clin Exp Rheumatol; 2019; 37 Suppl 118(3):159-166. PubMed ID: 30652677
[TBL] [Abstract][Full Text] [Related]
6. Increase of circulating memory B cells after glucocorticoid-induced remission identifies patients at risk of IgG4-related disease relapse.
Lanzillotta M; Della-Torre E; Milani R; Bozzolo E; Bozzalla-Cassione E; Rovati L; Arcidiacono PG; Partelli S; Falconi M; Ciceri F; Dagna L
Arthritis Res Ther; 2018 Oct; 20(1):222. PubMed ID: 30285841
[TBL] [Abstract][Full Text] [Related]
7. Circulating memory B cells and plasmablasts are associated with the levels of serum immunoglobulin in patients with ulcerative colitis.
Wang X; Jiang Y; Zhu Y; Zhang M; Li M; Wang H; Gao P
J Cell Mol Med; 2016 May; 20(5):804-14. PubMed ID: 26800315
[TBL] [Abstract][Full Text] [Related]
8. Identification of galectin-3 as an autoantigen in patients with IgG
Perugino CA; AlSalem SB; Mattoo H; Della-Torre E; Mahajan V; Ganesh G; Allard-Chamard H; Wallace Z; Montesi SB; Kreuzer J; Haas W; Stone JH; Pillai S
J Allergy Clin Immunol; 2019 Feb; 143(2):736-745.e6. PubMed ID: 29852256
[TBL] [Abstract][Full Text] [Related]
9. Plasmablasts as a biomarker for IgG4-related disease, independent of serum IgG4 concentrations.
Wallace ZS; Mattoo H; Carruthers M; Mahajan VS; Della Torre E; Lee H; Kulikova M; Deshpande V; Pillai S; Stone JH
Ann Rheum Dis; 2015 Jan; 74(1):190-5. PubMed ID: 24817416
[TBL] [Abstract][Full Text] [Related]
10. [IgG4-related disease -Mechanistic insights from both clinical and immunologic understanding of this condition].
Maehara T
Nihon Rinsho Meneki Gakkai Kaishi; 2017; 40(3):206-212. PubMed ID: 28747608
[TBL] [Abstract][Full Text] [Related]
11. Examination of the Level of Circulating Plasmablasts and Their Characteristics as Diagnostic Tools for Immunoglobulin G4-related Disease.
Tartakover Matalon S; Rabinowicz N; Carmi O; Zitman-Gal T; Drucker L; Levy Y
Isr Med Assoc J; 2024 Jun; 26(6):369-375. PubMed ID: 38884310
[TBL] [Abstract][Full Text] [Related]
12. Expansion of blood IgG
Heeringa JJ; Karim AF; van Laar JAM; Verdijk RM; Paridaens D; van Hagen PM; van Zelm MC
J Allergy Clin Immunol; 2018 May; 141(5):1831-1843.e10. PubMed ID: 28830675
[TBL] [Abstract][Full Text] [Related]
13. Clonally expanded cytotoxic CD4
Mattoo H; Stone JH; Pillai S
Autoimmunity; 2017 Feb; 50(1):19-24. PubMed ID: 28166682
[TBL] [Abstract][Full Text] [Related]
14. Quantitative measurement of 18F-FDG PET/CT uptake reflects the expansion of circulating plasmablasts in IgG4-related disease.
Berti A; Della-Torre E; Gallivanone F; Canevari C; Milani R; Lanzillotta M; Campochiaro C; Ramirez GA; Bozzalla Cassione E; Bozzolo E; Pedica F; Castiglioni I; Arcidiacono PG; Balzano G; Falconi M; Gianolli L; Dagna L
Rheumatology (Oxford); 2017 Dec; 56(12):2084-2092. PubMed ID: 28977663
[TBL] [Abstract][Full Text] [Related]
15. B-cell depletion attenuates serological biomarkers of fibrosis and myofibroblast activation in IgG4-related disease.
Della-Torre E; Feeney E; Deshpande V; Mattoo H; Mahajan V; Kulikova M; Wallace ZS; Carruthers M; Chung RT; Pillai S; Stone JH
Ann Rheum Dis; 2015 Dec; 74(12):2236-43. PubMed ID: 25143523
[TBL] [Abstract][Full Text] [Related]
16. IgG4-related disease.
Bozzalla Cassione E; Stone JH
Curr Opin Rheumatol; 2017 May; 29(3):223-227. PubMed ID: 28319486
[TBL] [Abstract][Full Text] [Related]
17. Pathogenesis of IgG4-related disease: a critical review.
Maehara T; Moriyama M; Nakamura S
Odontology; 2019 Apr; 107(2):127-132. PubMed ID: 30019169
[TBL] [Abstract][Full Text] [Related]
18. B-cells depletion after treatment with rituximab predicts relapse of IgG4-related disease.
Lanzillotta M; Ramirez GA; Milani R; Dagna L; Della-Torre E
Rheumatology (Oxford); 2024 May; ():. PubMed ID: 38781535
[TBL] [Abstract][Full Text] [Related]
19. Persistence and selection of an expanded B-cell clone in the setting of rituximab therapy for Sjögren's syndrome.
Hershberg U; Meng W; Zhang B; Haff N; St Clair EW; Cohen PL; McNair PD; Li L; Levesque MC; Luning Prak ET
Arthritis Res Ther; 2014 Feb; 16(1):R51. PubMed ID: 24517398
[TBL] [Abstract][Full Text] [Related]
20. Persistence of immunoglobulin-producing cells in parotid salivary glands of patients with primary Sjögren's syndrome after B cell depletion therapy.
Hamza N; Bootsma H; Yuvaraj S; Spijkervet FK; Haacke EA; Pollard RP; Visser A; Vissink A; Kallenberg CG; Kroese FG; Bos NA
Ann Rheum Dis; 2012 Nov; 71(11):1881-7. PubMed ID: 22615459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
